Iterative Cycle of Widely Targeted Metabolic Profiling for The

Total Page:16

File Type:pdf, Size:1020Kb

Iterative Cycle of Widely Targeted Metabolic Profiling for The Fathima et al. Biotechnol Biofuels (2018) 11:188 https://doi.org/10.1186/s13068-018-1187-8 Biotechnology for Biofuels RESEARCH Open Access Iterative cycle of widely targeted metabolic profling for the improvement of 1‑butanol titer and productivity in Synechococcus elongatus Artnice Mega Fathima1, Derrick Chuang2, Walter Alvarez Laviña1,3, James Liao2, Sastia Prama Putri1* and Eiichiro Fukusaki1 Abstract Background: Metabolomics is the comprehensive study of metabolites that can demonstrate the downstream efects of gene and protein regulation, arguably representing the closest correlation with phenotypic features. Hence, metabolomics-driven approach ofers an efective way to facilitate strain improvement. Previously, targeted metabolomics on the 1-butanol-producing cyanobacterial strain Synechococcus elongatus BUOHSE has revealed the reduction step from butanoyl-CoA to butanal, catalyzed by CoA-acylating propionaldehyde dehydrogenase (PduP), as a rate-limiting step in the CoA-dependent pathway. Moreover, an increase in acetyl-CoA synthesis rate was also observed in this strain, by which the increased rate of release of CoA from butanoyl-CoA was used to enhance forma- tion of acetyl-CoA to feed into the pathway. Results: In the present study, a new strain (DC7) with an improved activity of PduP enzyme, was constructed using BUOHSE as the background strain. DC7 showed a 33% increase in 1-butanol production compared to BUOHSE. For a deeper understanding of the metabolic state of DC7, widely targeted metabolomics approach using ion-pair reversed-phase LC/MS was performed. Results showed a decreased level of butanoyl-CoA and an increased level of acetyl-CoA in DC7 compared to BUOHSE. This served as an indication that the previous bottleneck has been solved and free CoA regeneration increased upon the improvement of the PduP enzyme. In order to utilize the enhanced levels of acetyl-CoA in DC7 for 1-butanol production, overexpression of acetyl-CoA carboxylase (ACCase) in DC7 was performed by inserting the gene encoding an ACCase subunit from Yarrowia lipolytica into the aldA site. The resulting strain, named DC11, was able to reach a production titer of 418.7 mg/L in 6 days, compared to DC7 that approached a similar titer in 12 days. A maximum productivity of 117 mg/L/day was achieved between days 4 and 5 in DC11. Conclusions: In this study, the iterative cycle of genetic modifcation based on insights from metabolomics success- fully resulted in the highest reported 1-butanol productivity for engineered Synechococcus elongatus PCC 7942. Keywords: Cyanobacteria, Butanol, Widely targeted metabolomics, Rate-limiting step, Strain improvement *Correspondence: [email protected]‑u.ac.jp 1 Department of Biotechnology, Graduate School of Engineering, Osaka University, 2‑1 Yamadaoka, Suita, Osaka 565‑0871, Japan Full list of author information is available at the end of the article © The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creat​iveco​mmons​.org/licen​ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat​iveco​mmons​.org/ publi​cdoma​in/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Fathima et al. Biotechnol Biofuels (2018) 11:188 Page 2 of 12 Background BUOHSE relative to EL22 due to a more efective conver- 1-Butanol is considered an important commodity chemi- sion of butanoyl-CoA to butanal by the PduP enzyme. cal and advanced biofuel [1]; thus, the introduction of a Surprisingly, the metabolome data indicated that the CoA-dependent pathway to produce 1-butanol in various amount of butanoyl-CoA was comparable to that of host organisms such as Escherichia coli [2, 3], Saccharo- EL22. Further analysis using kinetic profling showed myces cerevisiae [4], Pseudomonas putida, Lactobacillus that the release of CoA resulting from the introduction brevis, Bacillus subtilis [5, 6] and Cyanobacterium Syn- of PduP in BUOHSE enabled free CoA regeneration that echococcus elongatus [7] has become a common strategy in turn led to the increased rate of acetyl-CoA synthe- for microbial production. In addition, direct conversion sis. Here, the release of free CoA facilitated the reaction of CO2 to produce valuable products using photosyn- from pyruvate to acetyl-CoA, which was then used in the thetic organisms has garnered signifcant interest for butanol pathway [18]. Tese facts strongly indicate that its prospective role in attaining a carbon neutral society the reductive reaction of butanoyl-CoA to butanal should [8–13]. Cyanobacteria, photosynthetic microorganisms, be modifed further to improve 1-butanol productivity generally exhibit fast growth and genetic tractability, in the engineered cyanobacterial strain. In this work, we thus making them more advantageous as cell factories worked on further optimizing the PduP enzyme to facili- over eukaryotic algae and plants [14]. In relation to this, tate a more efective conversion from butanoyl-CoA to a cyanobacterial strain capable of producing 1-butanol butanal. In addition, since the previous analysis was only was engineered by introducing a modifed Clostridial limited to the CoA-dependent pathway, there is a pos- CoA-dependent pathway [15, 16]. Initially, Synechococcus sibility that other rate-limiting steps are present within elongatus strain EL22 was engineered using an oxygen- the 1-butanol-producing strain. Terefore, in the present sensitive enzyme, CoA-acylating butanal dehydrogenase study, widely targeted metabolic profling was used to (Bldh), for conversion of butanoyl-CoA to butanal and broaden the coverage of the metabolites analyzed, allow- was able to produce a low titer of 29.9 mg/L of 1-butanol ing for the identifcation of new rate-limiting steps in the [15]. Since oxygen sensitivity of Bldh hindered 1-butanol 1-butanol biosynthesis pathway to ultimately improve production, it was replaced with an oxygen-tolerant both titer and productivity. enzyme (PduP) in the BUOHSE strain, which resulted in a signifcant increase in 1-butanol production [16]. Results and discussion In recent years, metabolomics-based approaches for Comparative metabolite analysis of EL22 and BUOHSE strain improvement are widely being employed. Tis identifed rate‑limiting steps in 1‑butanol biosynthesis rapidly growing feld, focusing on the whole metabolite In this work, relative quantifcation approach for metabo- profle of a biological system, provides valuable informa- lomics was chosen over absolute quantifcation. It uses tion that can be applied in numerous ways [3, 17–20]. an internal standard to normalize the metabolite sig- By means of rapid detection of relevant metabolic per- nal intensity. Since this procedure is experimentally turbations, metabolomics can identify specifc targets less complicated and laborious, it allows for simultane- for strain improvement that may include identifcation ous profling of a larger number of metabolites as com- of rate limiting steps in a production pathway, metabo- pared to absolute quantifcation, thereby broadening the lite or product toxicity, cofactor imbalances, or deple- metabolite coverage [21, 22]. By using ion-pair reserved- tion of metabolites consumed by alternative pathways phase liquid chromatography triple quadrupole mass [3]. Terefore, a deeper understanding of the metabolic spectrometer (IP-RP-LC/QqQ-MS) system, 74 metabo- state of 1-butanol-producing strains can facilitate strain lites (Additional fle 1: Table S3) belonging to the central improvement by further strain modifcations. metabolism of Synechococcus elongatus strains EL22 and Previously, a targeted metabolomics analysis focusing BUOHSE were successfully annotated. on the CoA-dependent pathway in 1-butanol produc- In order to confrm that the previous rate-limiting step ing S. elongatus strain was performed by our previous can also be detected by using widely targeted analysis, research group [18]. In this published work, strains that the data were initially compared to the absolute quan- difer in enzymes that convert butanoyl-CoA to butanal tifcation data from previously published results [18]. were compared. Te introduction of an oxygen tolerant As mentioned previously, quantitative target analysis of (PduP) enzyme to replace the oxygen sensitive (BldH) acyl-CoAs suggested the accumulation of butanoyl-CoA enzyme was intended to increase the activity of this in BUOHSE as the rate-limiting step in 1-butanol biosyn- reaction in strain BUOHSE from base strain EL22. As a thesis. Tus, the relative concentration of butanoyl-CoA result, a major increase in 1-butanol titer was observed in in BUOHSE in comparison with EL22 was investigated. BUOHSE compared to EL22. Consequently, we expected As shown in Fig. 1a, our results also showed compa- to observe a decrease in the amount of butanoyl-CoA in rable levels of butanoyl-CoA in EL22 and BUOHSE, Fathima et al. Biotechnol Biofuels (2018) 11:188 Page 3 of 12 Fig. 1 a Relative intensity of intracellular butanoyl-CoA measurements from widely targeted metabolic profling of EL22 and BUOHSE. The y-axis represents the relative intensity of the metabolites, which was normalized to an internal standard. b Absolute intracellular concentration of butanoyl-CoA [pmol/mg-dry
Recommended publications
  • Synthetic Biology Applications in Industrial Microbiology
    SYNTHETIC BIOLOGY APPLICATIONS IN INDUSTRIAL MICROBIOLOGY Topic Editors Weiwen Zhang and David R. Nielsen MICROBIOLOGY FRONTIERS COPYRIGHT STATEMENT ABOUT FRONTIERS © Copyright 2007-2014 Frontiers is more than just an open-access publisher of scholarly articles: it is a pioneering Frontiers Media SA. All rights reserved. approach to the world of academia, radically improving the way scholarly research is managed. All content included on this site, such as The grand vision of Frontiers is a world where all people have an equal opportunity to seek, share text, graphics, logos, button icons, images, and generate knowledge. Frontiers provides immediate and permanent online open access to all video/audio clips, downloads, data compilations and software, is the property its publications, but this alone is not enough to realize our grand goals. of or is licensed to Frontiers Media SA (“Frontiers”) or its licensees and/or subcontractors. The copyright in the text of individual articles is the property of their FRONTIERS JOURNAL SERIES respective authors, subject to a license granted to Frontiers. The Frontiers Journal Series is a multi-tier and interdisciplinary set of open-access, online The compilation of articles constituting journals, promising a paradigm shift from the current review, selection and dissemination this e-book, wherever published, as well as the compilation of all other content on processes in academic publishing. this site, is the exclusive property of All Frontiers journals are driven by researchers for researchers; therefore, they constitute a service Frontiers. For the conditions for downloading and copying of e-books from to the scholarly community. At the same time, the Frontiers Journal Series operates on a revo- Frontiers’ website, please see the Terms lutionary invention, the tiered publishing system, initially addressing specific communities of for Website Use.
    [Show full text]
  • Index of Recommended Enzyme Names
    Index of Recommended Enzyme Names EC-No. Recommended Name Page 1.2.1.10 acetaldehyde dehydrogenase (acetylating) 115 1.2.1.38 N-acetyl-y-glutamyl-phosphate reductase 289 1.2.1.3 aldehyde dehydrogenase (NAD+) 32 1.2.1.4 aldehyde dehydrogenase (NADP+) 63 1.2.99.3 aldehyde dehydrogenase (pyrroloquinoline-quinone) 578 1.2.1.5 aldehyde dehydrogenase [NAD(P)+] 72 1.2.3.1 aldehyde oxidase 425 1.2.1.31 L-aminoadipate-semialdehyde dehydrogenase 262 1.2.1.19 aminobutyraldehyde dehydrogenase 195 1.2.1.32 aminomuconate-semialdehyde dehydrogenase 271 1.2.1.29 aryl-aldehyde dehydrogenase 255 1.2.1.30 aryl-aldehyde dehydrogenase (NADP+) 257 1.2.3.9 aryl-aldehyde oxidase 471 1.2.1.11 aspartate-semialdehyde dehydrogenase 125 1.2.1.6 benzaldehyde dehydrogenase (deleted) 88 1.2.1.28 benzaldehyde dehydrogenase (NAD+) 246 1.2.1.7 benzaldehyde dehydrogenase (NADP+) 89 1.2.1.8 betaine-aldehyde dehydrogenase 94 1.2.1.57 butanal dehydrogenase 372 1.2.99.2 carbon-monoxide dehydrogenase 564 1.2.3.10 carbon-monoxide oxidase 475 1.2.2.4 carbon-monoxide oxygenase (cytochrome b-561) 422 1.2.1.45 4-carboxy-2-hydroxymuconate-6-semialdehyde dehydrogenase .... 323 1.2.99.6 carboxylate reductase 598 1.2.1.60 5-carboxymethyl-2-hydroxymuconic-semialdehyde dehydrogenase . 383 1.2.1.44 cinnamoyl-CoA reductase 316 1.2.1.68 coniferyl-aldehyde dehydrogenase 405 1.2.1.33 (R)-dehydropantoate dehydrogenase 278 1.2.1.26 2,5-dioxovalerate dehydrogenase 239 1.2.1.69 fluoroacetaldehyde dehydrogenase 408 1.2.1.46 formaldehyde dehydrogenase 328 1.2.1.1 formaldehyde dehydrogenase (glutathione)
    [Show full text]
  • Brockarchaeota, a Novel Archaeal Phylum with Unique and Versatile Carbon Cycling Pathways
    Lawrence Berkeley National Laboratory Recent Work Title Brockarchaeota, a novel archaeal phylum with unique and versatile carbon cycling pathways. Permalink https://escholarship.org/uc/item/2gn7m5pw Journal Nature communications, 12(1) ISSN 2041-1723 Authors De Anda, Valerie Chen, Lin-Xing Dombrowski, Nina et al. Publication Date 2021-04-23 DOI 10.1038/s41467-021-22736-6 Peer reviewed eScholarship.org Powered by the California Digital Library University of California ARTICLE https://doi.org/10.1038/s41467-021-22736-6 OPEN Brockarchaeota, a novel archaeal phylum with unique and versatile carbon cycling pathways Valerie De Anda 1, Lin-Xing Chen2, Nina Dombrowski 1,3, Zheng-Shuang Hua 4, Hong-Chen Jiang5, ✉ ✉ Jillian F. Banfield 2,6, Wen-Jun Li 7,8 & Brett J. Baker 1 Geothermal environments, such as hot springs and hydrothermal vents, are hotspots for carbon cycling and contain many poorly described microbial taxa. Here, we reconstructed 15 1234567890():,; archaeal metagenome-assembled genomes (MAGs) from terrestrial hot spring sediments in China and deep-sea hydrothermal vent sediments in Guaymas Basin, Gulf of California. Phylogenetic analyses of these MAGs indicate that they form a distinct group within the TACK superphylum, and thus we propose their classification as a new phylum, ‘Brock- archaeota’, named after Thomas Brock for his seminal research in hot springs. Based on the MAG sequence information, we infer that some Brockarchaeota are uniquely capable of mediating non-methanogenic anaerobic methylotrophy, via the tetrahydrofolate methyl branch of the Wood-Ljungdahl pathway and reductive glycine pathway. The hydrothermal vent genotypes appear to be obligate fermenters of plant-derived polysaccharides that rely mostly on substrate-level phosphorylation, as they seem to lack most respiratory complexes.
    [Show full text]
  • Wo 2008/115840 A2
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date PCT (10) International Publication Number 25 September 2008 (25.09.2008) WO 2008/115840 A2 (51) International Patent Classification: (74) Agents: GAY,David, A. et al; McDermott, Will & Emery C12N 1/21 (2006.01) LLP,4370LaIoIIa Village Drive, Suite 700, San Diego, CA 92122 (US). (21) International Application Number: (81) Designated States (unless otherwise indicated, for every PCT/US2008/057168 kind of national protection available): AE, AG, AL, AM, (22) International Filing Date: 14 March 2008 (14.03.2008) AO, AT,AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, (25) Filing Language: English EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, IP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, (26) Publication Language: English LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, (30) Priority Data: PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, 60/918,463 16 March 2007 (16.03.2007) US SY, TI, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW (71) Applicant (for all designated States except US): GENO- (84) Designated States (unless otherwise indicated, for every MATICA, INC. [US/US]; 5405 Morehouse Drive, Suite kind of regional protection available): ARIPO (BW, GH, 210, San Diego, CA 92121 (US).
    [Show full text]
  • An in Silico Characterization of Microbial Electrosynthesis for Metabolic Engineering of Biochemicals
    An in silico Characterization of Microbial Electrosynthesis for Metabolic Engineering of Biochemicals by Aditya Pandit A thesis submitted in conformity with the requirement for the degree of Masters of Applied Science Graduate Department of Chemical Engineering and Applied Chemistry University of Toronto (c) Copyright by Aditya Pandit 2012 An in silico Characterization of Microbial Electrosynthesis for Metabolic Engineering of Biochemicals Aditya Vikram Pandit Masters of Applied Science Graduate Department of Chemical Engineering and Applied Chemistry University of Toronto 2012 ABSTRACT A critical concern in metabolic engineering is the need to balance the demand and supply of redox intermediates. Bioelectrochemical techniques offer a promising method to alleviate redox imbalances during the synthesis of biochemicals. Broadly, these techniques reduce intracellular NAD+ to NADH and therefore manipulate the cell‘s redox balance. The cellular response to such redox changes and the additional reducing can be harnessed to produce desired metabolites. In the context of microbial fermentation, these bioelectrochemical techniques can improve product yields and/or productivity. We have developed a method to characterize the role of bioelectrosynthesis in chemical production using the genome-scale metabolic model of E. coli. The results elucidate the role of bioelectrosynthesis and its impact on biomass growth, cellular ATP yields and biochemical production. The results also suggest that strain design strategies can change for fermentation ii processes that employ microbial electrosynthesis and suggest that dynamic operating strategies lead to maximizing productivity. iii ACKNOWLEDGMENTS I would like to give my thanks to my supervisor, Prof. Mahadevan for giving me the opportunity to do my masters degree in his lab.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,175,297 B2 Burk Et Al
    US009 175297B2 (12) United States Patent (10) Patent No.: US 9,175,297 B2 Burk et al. (45) Date of Patent: Nov. 3, 2015 (54) MCROORGANISMIS FOR THE (2013.01); C12N 15/52 (2013.01); C12N 15/70 PRODUCTION OF 1,4-BUTANEDIOL (2013.01); CI2P 7/18 (2013.01); C12Y 101/01157 (2013.01); C12Y402/01055 (75) Inventors: Mark J. Burk, San Diego, CA (US); (2013.01) Anthony P. Burgard, Bellefonte, PA (58) Field of Classification Search (US); Robin E. Osterhout, San Diego, CPC .......... C12N 15/81, C12N 15/70; C12N 9/10: CA (US); Jun Sun, San Diego, CA (US) C12N 9/93 (73) Assignee: Genomatica, Inc., San Diego, CA (US) See application file for complete search history. (*) Notice: Subject to any disclaimer, the term of this (56) References Cited patent is extended or adjusted under 35 U.S. PATENT DOCUMENTS U.S.C. 154(b) by 283 days. 4,048,196 A 9, 1977 Broecker et al. (21) Appl. No.: 13/449,187 4,301,077 A 11/1981 Pesa et al. (22) Filed: Apr. 17, 2012 (Continued) FOREIGN PATENT DOCUMENTS (65) Prior Publication Data GB 1230276 4f1971 US 2013/O109069 A1 May 2, 2013 GB 1314126 4f1973 Related U.S. Application Data (Continued) (63) Continuation of application No. 13/009,813, filed on OTHER PUBLICATIONS Jan. 19, 2011, now Pat. No. 8,178,327, which is a continuation of application No. 127947,790, filed on Abe et al., “BioSynthesis from gluconate of a random copolyester Nov. 16, 2010, now Pat. No. 8,129,156, which is a consisting of 3-hydroxybutyrate and medium-chain-length continuation of application No.
    [Show full text]
  • All Enzymes in BRENDA™ the Comprehensive Enzyme Information System
    All enzymes in BRENDA™ The Comprehensive Enzyme Information System http://www.brenda-enzymes.org/index.php4?page=information/all_enzymes.php4 1.1.1.1 alcohol dehydrogenase 1.1.1.B1 D-arabitol-phosphate dehydrogenase 1.1.1.2 alcohol dehydrogenase (NADP+) 1.1.1.B3 (S)-specific secondary alcohol dehydrogenase 1.1.1.3 homoserine dehydrogenase 1.1.1.B4 (R)-specific secondary alcohol dehydrogenase 1.1.1.4 (R,R)-butanediol dehydrogenase 1.1.1.5 acetoin dehydrogenase 1.1.1.B5 NADP-retinol dehydrogenase 1.1.1.6 glycerol dehydrogenase 1.1.1.7 propanediol-phosphate dehydrogenase 1.1.1.8 glycerol-3-phosphate dehydrogenase (NAD+) 1.1.1.9 D-xylulose reductase 1.1.1.10 L-xylulose reductase 1.1.1.11 D-arabinitol 4-dehydrogenase 1.1.1.12 L-arabinitol 4-dehydrogenase 1.1.1.13 L-arabinitol 2-dehydrogenase 1.1.1.14 L-iditol 2-dehydrogenase 1.1.1.15 D-iditol 2-dehydrogenase 1.1.1.16 galactitol 2-dehydrogenase 1.1.1.17 mannitol-1-phosphate 5-dehydrogenase 1.1.1.18 inositol 2-dehydrogenase 1.1.1.19 glucuronate reductase 1.1.1.20 glucuronolactone reductase 1.1.1.21 aldehyde reductase 1.1.1.22 UDP-glucose 6-dehydrogenase 1.1.1.23 histidinol dehydrogenase 1.1.1.24 quinate dehydrogenase 1.1.1.25 shikimate dehydrogenase 1.1.1.26 glyoxylate reductase 1.1.1.27 L-lactate dehydrogenase 1.1.1.28 D-lactate dehydrogenase 1.1.1.29 glycerate dehydrogenase 1.1.1.30 3-hydroxybutyrate dehydrogenase 1.1.1.31 3-hydroxyisobutyrate dehydrogenase 1.1.1.32 mevaldate reductase 1.1.1.33 mevaldate reductase (NADPH) 1.1.1.34 hydroxymethylglutaryl-CoA reductase (NADPH) 1.1.1.35 3-hydroxyacyl-CoA
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2015/0307854 A1 B0tes Et Al
    US 20150307854A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2015/0307854 A1 B0tes et al. (43) Pub. Date: Oct. 29, 2015 (54) METHODS OF PRODUCING 6-CARBON Publication Classification CHEMICALS VA COA-DEPENDENT CARBON CHAIN ELONGATION (51) Int. Cl. ASSOCATED WITH CARBON STORAGE CI2N 9/02 (2006.01) CI2P 7/44 (2006.01) (71) Applicant: INVISTA North America S.ár.l., (52) U.S. Cl. Wilmington, DE (US) CPC ....... CI2N 9/0008 (2013.01); C12Y 102/02001 (2013.01); CI2P 7/44 (2013.01) (72) Inventors: Adriana Leonora Botes, Rosedale East (GB); Alex Van Eck Conradie, Eaglescliffe (GB) (57) ABSTRACT (21) Appl. No.: 14/666,055 This document describes biochemical pathways for produc ing adipic acid, caprolactam, 6-aminohexanoic acid, hexam (22) Filed: Mar. 23, 2015 ethylenediamine or 1.6-hexanediol by forming two terminal functional groups, comprised of carboxyl, amine or hydroxyl Related U.S. Application Data groups, in a C6 aliphatic backbone Substrate. These path ways, metabolic engineering and cultivation strategies (62) Division of application No. 13/715,981, filed on Dec. described herein rely on CoA-dependent elongation enzymes 14, 2012, now Pat. No. 9,102.958. or analogues enzymes associated with the carbon Storage (60) Provisional application No. 61/576,401, filed on Dec. pathways from polyhydroxyalkanoate accumulating bacte 16, 2011. 18. Patent Application Publication Oct. 29, 2015 Sheet 1 of 8 US 2015/0307854 A1 Patent Application Publication Oct. 29, 2015 Sheet 2 of 8 US 2015/0307854 A1 3. EC 38 Patent Application Publication Oct. 29, 2015 Sheet 3 of 8 US 2015/0307854 A1 Patent Application Publication Oct.
    [Show full text]
  • UC Davis UC Davis Previously Published Works
    UC Davis UC Davis Previously Published Works Title Strategies for Enhancing the Effectiveness of Metagenomic-based Enzyme Discovery in Lignocellulolytic Microbial Communities Permalink https://escholarship.org/uc/item/5bh2q8rd Journal BioEnergy Research, 3(2) ISSN 1939-1242 Authors DeAngelis, Kristen M. Gladden, John M. Allgaier, Martin et al. Publication Date 2010-06-01 DOI 10.1007/s12155-010-9089-z Peer reviewed eScholarship.org Powered by the California Digital Library University of California Bioenerg. Res. (2010) 3:146–158 DOI 10.1007/s12155-010-9089-z Strategies for Enhancing the Effectiveness of Metagenomic-based Enzyme Discovery in Lignocellulolytic Microbial Communities Kristen M. DeAngelis & John M. Gladden & Martin Allgaier & Patrik D’haeseleer & Julian L. Fortney & Amitha Reddy & Philip Hugenholtz & Steven W. Singer & Jean S. Vander Gheynst & Whendee L. Silver & Blake A. Simmons & Terry C. Hazen Published online: 30 March 2010 # The Author(s) 2010. This article is published with open access at Springerlink.com Abstract Producing cellulosic biofuels from plant material are often too complex for enzyme discovery using current has recently emerged as a key US Department of Energy metagenomic sequencing technologies. One potential strat- goal. For this technology to be commercially viable on a egy to overcome this problem is to selectively cultivate the large scale, it is critical to make production cost efficient by microbial communities from these complex ecosystems on streamlining both the deconstruction of lignocellulosic biomass under defined conditions, generating less complex biomass and fuel production. Many natural ecosystems biomass-degrading microbial populations. To test this efficiently degrade lignocellulosic biomass and harbor premise, we cultivated microbes from Puerto Rican soil or enzymes that, when identified, could be used to increase green waste compost under precisely defined conditions in the the efficiency of commercial biomass deconstruction.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0319313 A1 SUN Et Al
    US 201603.1931.3A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2016/0319313 A1 SUN et al. (43) Pub. Date: Nov. 3, 2016 (54) MICROORGANISMS AND METHODS FOR continuation of application No. 12/940,021, filed on THE COPRODUCTION 1,4-BUTANEDIOL Nov. 4, 2010, now Pat. No. 8,530,210. AND GAMMA-BUTYROLACTONE (60) Provisional application No. 61/264,598, filed on Nov. (71) Applicant: Genomatica, Inc., San Diego, CA (US) 25, 2009. Publication Classification (72) Inventors: Jun SUN, San Diego, CA (US); Mark J. BURK, San Diego, CA (US); (51) Int. Cl. Anthony P. BURGARD, Bellefonte, CI2P I 7/04 (2006.01) CA (US); Robin E. OSTERHOUT, CI2N 15/52 (2006.01) San Diego, CA (US); Wei NIU, CI2P 7/18 (2006.01) Lincoln, NE (US); John D. (52) U.S. Cl. TRAWICK, La Mesa, CA (US); CPC .................. CI2P 17/04 (2013.01); C12P 7/18 Robert HASELBECK, San Diego, CA (2013.01); C12N 15/52 (2013.01) (US) (57) ABSTRACT (21) Appl. No.: 14/954,487 The invention provides non-naturally occurring microbial organisms comprising 1,4-butanediol (14-BDO) and (22) Filed: Nov. 30, 2015 gamma-butyrolactone (GBL) pathways comprising at least one exogenous nucleic acid encoding a 14-BDO and GBL pathway enzyme expressed in a Sufficient amount to produce Related U.S. Application Data 14-BDO and GBL. The invention additionally provides (63) Continuation of application No. 13/936,878, filed on methods of using Such microbial organisms to produce Jul. 8, 2013, now Pat. No. 9,222,113, which is a 14-BDO and GBL.
    [Show full text]
  • KO Id Functional Hierarchy 1 Functional Hierarchy 2 Module Id Module Description Name Definition Life Style K00611 Amino Acid Me
    KO_id Functional hierarchy 1 Functional hierarchy 2 Module_id Module description Name Definition Life_style K00611 Amino acid metabolism Arginine and proline metabolism M00029 Urea cycle [PATH:map00220 map01230 map01100] OTC, argF, argI ornithine carbamoyltransferase [EC:2.1.3.3] FL-ls K00611 Amino acid metabolism Arginine and proline metabolism M00844 Arginine biosynthesis, ornithine => arginine [PATH:map00220OTC, map01230argF, argI map01100]ornithine carbamoyltransferase [EC:2.1.3.3] FL-ls K00286 Amino acid metabolism Arginine and proline metabolism M00015 Proline biosynthesis, glutamate => proline [PATH:map00330proC map01230 map01100]pyrroline-5-carboxylate reductase [EC:1.5.1.2] PA-ls K00818 Amino acid metabolism Arginine and proline metabolism M00028 Ornithine biosynthesis, glutamate => ornithine [PATH:map00220E2.6.1.11, map01210 argD map01230acetylornithine map01100] aminotransferase [EC:2.6.1.11] PA-ls K00619 Amino acid metabolism Arginine and proline metabolism M00028 Ornithine biosynthesis, glutamate => ornithine [PATH:map00220argA map01210 map01230amino-acid map01100] N-acetyltransferase [EC:2.3.1.1] PA-ls K00620 Amino acid metabolism Arginine and proline metabolism M00028 Ornithine biosynthesis, glutamate => ornithine [PATH:map00220argJ map01210 map01230glutamate map01100] N-acetyltransferase / amino-acid N-acetyltransferasePA-ls [EC:2.3.1.35 2.3.1.1] K00930 Amino acid metabolism Arginine and proline metabolism M00028 Ornithine biosynthesis, glutamate => ornithine [PATH:map00220argB map01210 map01230acetylglutamate map01100]
    [Show full text]
  • Non-Natural Microbial Organisms with Improved
    (19) *EP003194604B1* (11) EP 3 194 604 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C12P 7/42 (2006.01) C12P 7/16 (2006.01) 26.02.2020 Bulletin 2020/09 (86) International application number: (21) Application number: 15775307.0 PCT/US2015/050923 (22) Date of filing: 18.09.2015 (87) International publication number: WO 2016/044713 (24.03.2016 Gazette 2016/12) (54) NON-NATURAL MICROBIAL ORGANISMS WITH IMPROVED ENERGETIC EFFICIENCY NICHT-NATÜRLICHE MIKROBIELLE ORGANISMEN MIT VERBESSERTER ENERGIEEFFIZIENZ ORGANISMES MICROBIENS NON NATURELS PRÉSENTANT UNE MEILLEURE EFFICACITÉ ÉNERGÉTIQUE (84) Designated Contracting States: • V. Monedero ET AL: "Mutations lowering the AL AT BE BG CH CY CZ DE DK EE ES FI FR GB phosphatase activity of HPr kinase/phosphatase GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO switch off carbon metabolism.", The EMBO PL PT RO RS SE SI SK SM TR journal, vol. 20, no. 15 1 August 2001 (2001-08-01), 1 August 2001 (2001-08-01), pages 3928-3937, (30) Priority: 18.09.2014 US 201462052341 P XP055233568, Retrieved from the Internet: URL:http://emboj.embopress.org/content/20/ (43) Date of publication of application: 15/3928.full.pdf [retrieved on 2015-12-03] 26.07.2017 Bulletin 2017/30 • MARTA PAPINI ET AL: "Physiological characterization of recombinant Saccharomyces (73) Proprietor: Genomatica, Inc. cerevisiae expressing the phosphoketolase San Diego, CA 92121 (US) pathway: validation of activity through 13C-based metabolic flux analysis", APPLIED (72) Inventors: MICROBIOLOGY AND BIOTECHNOLOGY, • PHARKYA, Priti SPRINGER, BERLIN, DE, vol.
    [Show full text]